Medeiros, Felipe A.
Sheybani, Arsham
Shah, Manjool M.
Rivas, Marcos
Bai, Zhanying
Werts, Erica
Ahmed, Iqbal I. K.
Craven, E. Randy
Clinical trials referenced in this document:
Documents that mention this clinical trial
Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension
https://doi.org/10.1007/s40123-022-00527-6
Documents that mention this clinical trial
Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension
https://doi.org/10.1007/s40123-022-00527-6
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
https://doi.org/10.1007/s40265-021-01624-9
Documents that mention this clinical trial
Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension
https://doi.org/10.1007/s40123-022-00527-6
Funding for this research was provided by:
Allergan, an AbbVie company
Article History
Received: 13 April 2022
Accepted: 9 May 2022
First Online: 28 May 2022